Feature Head to head

Should you tell patients about beneficial treatments that they cannot have? No

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39171.511794.AD (Published 19 April 2007) Cite this as: BMJ 2007;334:827
  1. John Firth, consultant nephrologist
  1. Addenbrooke's Hospital, Cambridge CB2 2QQ
  1. jfirth{at}doctors.org.uk

    No healthcare system can afford to pay for all available treatments. Robert Marcus believes doctors have a duty to tell patients about unfunded drugs, but John Firth argues that it will cause them harm

    I am a kidney doctor. Mr Brown, a frail 79 year old man who lives in social housing, comes to my clinic. He has advanced chronic renal failure, cause unknown, but not so far advanced that dialysis would be likely to benefit him, and in previous discussion with me and the dialysis nurses he has said that he doesn't want it in the future anyway. He tells me that he is tired, has no energy, and getting around is more of an effort than it used to be, but he is eating satisfactorily and his diagnosis is that he thinks he's getting old. His haemoglobin is 101 g/l.

    I suspect that he would feel better if his haemoglobin was higher. He is not iron deficient. Erythropoietin would be the most appropriate treatment on clinical grounds and …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe